全球導尿管帽市場：市場規模、佔有率和趨勢分析（2026-2032 年）

全球導尿管帽市場報告（至2032年）

2025年全球導管帽市場規模為3.49億美元。預計該市場將以3.1%的複合年成長率成長，到2032年將超過4.33億美元。

本報告涵蓋全球導管帽市場，包括用於連接通路點的無針連接器和用於覆蓋導管端口的一次性消毒裝置。

分析內容包括銷售量、平均售價（ASP）、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要受長期留置導管使用率提高、人口結構變化、導管利用率上升等因素所驅動。然而，導管使用壽命期間導管帽的總成本以及抗菌型PICC和CVC使用量的增加，仍然限制市場的進一步擴張。

市場概覽

全球導管帽市場包括用於抑制導管接頭、無針連接器和開放式導管端口中微生物定植的抗菌帽。

導管帽通常是含有消毒劑的一次性產品。當連接到導管接頭或連接器上時，它們會在接觸殘留液體時釋放消毒劑，從而在兩次導管操作之間提供被動消毒。

這些裝置作為輔助產品，用於預防血管通路護理整體的感染。它們在長期導管留置（例如PICC和CVC）中尤其重要，因為這些導管留置時間較長，感染預防是主要關注點。

導管使用的基本趨勢持續支撐著長期成長。人口老化和慢性病盛行率上升導致住院率增加，對靜脈通路裝置的依賴性也隨之增強。由於大多數住院患者在住院期間至少會插入一根導管，導管置入量的增加直接推動了對導管帽的需求。

市場促進因素

長期留置導尿管的廣泛應用

導管帽在長期導管置入中的日益普及是推動市場成長的主要因素。中央靜脈導管（如PICC和CVC）由於長期留置，感染風險顯著較高。

降低感染率是醫療機構的首要任務。治療導管相關性血流感染可能耗時費力，且會對患者預後產生負面影響。

一些導管帽產品已被證實可將導管相關血流感染的發生率降低 40% 至 70%。這種臨床價值正在推動其應用，尤其是在高風險導管類別中。

目前估計，僅約30%的中央靜脈導管使用導管帽。隨著越來越多的醫院將消毒導管帽納入中央靜脈導管管理流程，其市場成長潛力巨大。

人口統計因素

人口因素也在推動導尿管帽市場的發展。全球人口年增率約為0.9%，而老年人口年增率約為1.8%。

這些人口結構變化導致住院人數增加。老年患者更可能需要輸液治療、慢性病管理、中心靜脈通路、透析通路或其他基於導管的照護。

絕大多數住院患者都會使用某種形式的導尿管。隨著導尿管使用量的增加，預計在預測期內，包括導尿管帽在內的感染預防用品的需求將會增加。

感染預防和被動消毒

感染預防仍是採用導管帽時的核心考量。導管接頭和無針連接器是經常操作的部位，重複操作導管會增加微生物污染的風險。

導管帽可在兩次穿刺之間提供持續的被動消毒。這意味著即使醫護人員不主動清潔連接器，裝置也能幫助保護網路基地台。

這種被動式工作流程優勢在繁忙的醫院環境中至關重要。消毒帽有助於規範消毒程序，減少對人工操作的依賴，並支持急診和長期照護機構的感染預防方案。

市場限制

導管帽在整個使用壽命期間成本相對較高。

導管帽在導管使用壽命期間的總成本是限制市場發展的主要因素。單一導管帽價格相對低廉，對於PICC和CVC等高價導管而言，許多醫療機構認為其成本合理。

然而，對於像 PIVC 這樣的低成本設備，導管使用壽命期間使用的導管帽的總成本可能接近導管本身的成本。

在這方面，在外周靜脈留置針上使用消毒帽實際上會使該裝置的成本翻倍。大量使用外周靜脈留置針的機構可能認為這種成本增加並不合理。

由於周邊靜脈置管是插入最廣泛的導管，因此該領域的進入門檻預計將限制導管帽市場的整體成長。

抗菌PICC和CVC使用增加

抗菌型PICC和CVC使用量的增加是另一個重要的限制因素。中央靜脈導管擴大採用先進材料製成，旨在減少血流感染。

這些抗菌導管的作用與導管帽類似，都能降低導管使用相關的感染風險。隨著這些先進設備不斷滲透市場，一些醫療機構可能會質疑是否還需要其他產品。

如果醫院認為使用抗菌導管已能有效預防感染，則其購買所有穿刺部位導管帽的意願可能會降低。這可能會限制導管帽的引入，尤其是在那些試圖控制血管通路成本的醫療機構中。

導管使用量高時，成本敏感度較高

每次使用導管端口時都需要更換導管帽，導致導管帽需要重複使用。這造成了持續穩定的市場需求，但也提高了對成本的敏感度。

在導尿管使用率高的環境中，每根導尿管每天可能需要使用多個導尿管帽。雖然這會增加銷量，但也增加了將導尿管帽作為標準作業流程一部分的總成本。

醫療機構需要權衡重複使用帽子的成本與預防感染帶來的潛在成本節約。如果感染風險較低或預算有限，實施速度可能會較慢。

市場覆蓋範圍和數據範圍

• 定量研究範圍：市場規模、市場佔有率、市場預測、市場成長率、銷售量、平均售價。
• 定性研究範圍：市場促進因素和限制因素、競爭分析、近期併購、公司概況、產品系列和主要競爭對手。
• 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
• 建立市場模型：利用銷售量和平均售價（ASP）分析收入，並輔以競爭佔有率分析和預測假設。
• 目標器械：本報告重點介紹用於消毒無針連接器和打開不同通路點之間導管端口的導管帽。這些器械整體血管通路環境中，作為感染預防輔助工具。

目標市場及區隔

導管帽市場

本報告涵蓋了全球導管帽市場，作為專業血管通路配件的細分市場。

導管帽是一種一次性消毒裝置，用於覆蓋無針連接器，使導管端口在穿刺點之間保持開放。它通常含有消毒劑，當與導管接頭內的殘留液體接觸時，消毒劑會釋放出來。

這些蓋子可提供持續的被動消毒，並有助於防止管線操作間隙的網路基地台微生物定植。

本報告分析了市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價。

需求評估依據包括導管使用情況、中央靜脈導管採用、感染預防方案、周邊靜脈導管 (PIVC) 滲透率、長期導管使用、人口趨勢和競爭格局。

這種配置使製造商、投資者和策略團隊能夠了解感染預防優先事項、導管放置率、產品成本以及先進抗菌導管技術的擴展如何影響導管帽的採用。

競爭分析

2024年4月，3M完成了醫療保健業務的計畫分拆，正式推出了Solventum公司。 2025年，Solventum以其Curos™系列消毒產品，在導管帽市場佔了領先地位。

Curos™ 導管蓋專為導管端口消毒而設計，適用於無針式和魯爾接頭。本產品含有異丙醇溶液，證實可在 1 分鐘內對開放式導管端口進行消毒。

本產品可提供長達7天的保護，每次使用導管連接埠時均需更換。由於導管端口可能每天多次使用，因此需要重複使用保護帽，從而確保了穩定的銷售。

Solventum強調了Curos™帽與治療感染疾病相比具有潛在的成本節約優勢。雖然研究結果各不相同，但許多估計表明，使用Curos™帽可節省超過3萬美元的費用。

Solventum在導管固定市場也處於領先地位，其產品包括Tegaderm™敷料和Curos™帽。這廣泛的血管通路感染預防產品組合鞏固了公司的市場地位。

自2019年收購Pursuit Vascular以來，ICU Medical已成為導管帽市場，尤其是透析導管帽領域，的第二大廠商。 Pursuit Vascular的ClearGuard® HD導管帽以氯己定進行消毒，據報道可將導管相關血流感染的發生率降低約70%。

技術和臨床趨勢

被動消毒

被動消毒是導管帽市場的一大趨勢。由於導管帽即使在換用導管之間也始終連接在連接器或導管端口上，因此無需反覆手動清潔即可保持消毒狀態。

這有助於建立更規範的感染預防工作流程。

異丙醇蓋

異丙醇基導管蓋在市場上仍佔有重要地位。 Solventum 的 Curos™ 系列產品採用異丙醇溶液對開放式導管端口和無針連接器進行消毒。

這些產品廣泛用於血管通路感染預防方案。

氯己定透析帽

在透析應用中，含氯己定的導管帽非常重要。 ICU Medical 的 ClearGuard® HD 導管帽採用氯己定進行消毒，旨在減少血液透析通路中導管相關的血流感染。

這鞏固了 ICU Medical 在透析相關應用領域中導管帽的使用地位。

預防中央靜脈導管相關感染疾病

由於中央靜脈導管（如 PICC 和 CVC）留置時間長、感染風險高，因此它們仍然是導管帽的主要目標。

據估計，目前只有約 30% 的中央靜脈導管使用導管帽，因此這代表著一個巨大的成長機會。

PIVC的成本挑戰

PIVC 的引入仍然面臨挑戰，因為使用導管帽的總成本可能接近甚至超過導管本身的成本。

為了擴大 PIVC 的採用範圍，企業可能需要更有力的經濟證據或成本更低的封頂方案。

與抗菌導管的競爭

為了降低血流感染的風險，抗菌型PICC和CVC的使用正在增加。這些產品可能會減少對單獨導管帽的需求。

這一趨勢可能會導致一些場所對引入容量限制做出規定。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

• 全球導尿管帽市場目前的規模有多大？預計到 2032 年將成長多少？
• 銷售量、平均售價和市場規模如何隨時間變化？
• 導管帽如何支援無針連接器和開放式導管端口的被動消毒？
• 長期留置導尿管使用量的增加對導尿管帽的需求有何影響？
• 為什麼 PICC（經靜脈中央靜脈導管）和 CVC（中央靜脈導管）代表導管帽的巨大成長機會？
• 導管帽如何降低導管相關性血流感染的風險？
• 為什麼重複使用瓶蓋會成為實施 PIVC 的成本障礙？
• 抗菌型PICC和CVC對乳管帽的需求有何影響？
• 全球導尿管帽市場的主要參與者有哪些？
• Solventum 和 ICU Medical 在標準的導管帽、透析帽和血管通路感染預防工作流程中扮演什麼角色？

iData Research 的「全球導尿管帽市場報告」透過設備層面的分析、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估需求、比較競爭對手、了解被動消毒技術的應用情況以及製定全球導尿管帽市場的產業計畫。

目錄

調查方法

• 步驟 1：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 步驟 4：進行初步調查
• 步驟 5：調查與分析：建立基準估計值
• 步驟 6：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟 9：客戶回饋與市場監測

全球關稅的影響

導管帽市場

• 摘要整理
  • 全球導尿管帽市場概覽
  • 競爭分析
  • 目標區域
• 介紹
• 市場分析與預測
• 促進因素和抑制因素
• 競爭性市佔率分析

簡稱

Global Catheter Cap Market Report to 2032

The global catheter cap market was valued at $349 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching over $433 million by 2032.

This report covers the global market for catheter caps, including single-use disinfection devices designed to cover needleless connectors and open catheter ports between accesses.

The analysis includes unit sales, average selling prices (ASPs), market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by increased uptake with long-term catheters, demographic trends, and rising catheter utilization. However, the total cost of caps over a catheter's lifetime and the increased use of antimicrobial PICCs and CVCs continue to limit stronger expansion.

Market Overview

The global catheter cap market includes disinfection caps used to reduce microbial colonization at catheter hubs, needleless connectors, and open catheter ports.

Catheter caps are single-use products that typically contain an antiseptic agent. When applied to the catheter hub or connector, the antiseptic is released upon contact with residual fluid, providing passive disinfection between line manipulations.

These devices are used as adjunct infection-prevention products across vascular access care. They are especially relevant for long-term catheters such as PICCs and CVCs, where catheter dwell time is longer and infection prevention is a major concern.

Underlying catheter utilization trends continue to support long-term growth. Aging populations and rising prevalence of chronic disease are increasing hospitalization rates and reliance on vascular access devices. Since most hospitalized patients receive at least one catheter during their stay, growth in catheter placements directly supports demand for catheter caps.

Market Drivers

Increased Uptake of Long-Term Catheters

Increased uptake of catheter caps with long-term catheters is a major driver of the market. Central line catheters such as PICCs and CVCs have a significantly higher infection risk because of their longer dwell times.

Reducing infection rates is a primary concern for healthcare facilities. Treating catheter-related bloodstream infections can be costly, time consuming, and harmful to patient outcomes.

Some catheter cap products have been shown to reduce catheter-related bloodstream infections by 40% to 70%. This clinical value supports adoption, especially in higher-risk catheter categories.

It is currently estimated that only approximately 30% of all central lines use catheter caps. This leaves a significant opportunity for growth as more hospitals adopt disinfection caps as part of central line management protocols.

Demographic Factors

Demographic factors also support the catheter cap market. The world population is increasing at approximately 0.9% per year, while the elderly population is increasing at around 1.8% per year.

This demographic shift is contributing to an increased number of hospitalizations. Older patients are more likely to require infusion therapy, chronic disease management, central venous access, dialysis access, or other forms of catheter-based care.

The vast majority of hospitalized patients receive some type of catheter. As catheter use rises, demand for adjunct infection-prevention products, including catheter caps, is expected to grow over the forecast period.

Infection Prevention and Passive Disinfection

Infection prevention remains central to catheter cap adoption. Catheter hubs and needleless connectors are frequent access points, and repeated line manipulation increases the risk of microbial contamination.

Catheter caps provide continuous passive disinfection between accesses. This means the device helps protect the access point even when staff are not actively cleaning the connector.

This passive workflow advantage is important in busy hospital environments. Caps can help standardize disinfection practices, reduce reliance on manual compliance alone, and support infection-prevention protocols across both acute and long-term care settings.

Market Limiters

Relatively High Cost of Caps Over Catheter Lifetime

The cost of catheter caps over the lifetime of the catheter is a major market limiter. Individual catheter caps are relatively inexpensive, and for higher-priced catheters such as PICCs and CVCs, many healthcare providers view the cost as justifiable.

However, for lower-priced devices such as PIVCs, the total cost of caps used over the catheter's lifetime can approach the cost of the catheter itself.

In this context, using disinfection caps for PIVCs can effectively double the cost of the device. Some facilities may not view this as a justified increase, especially when PIVCs are used in very high volumes.

Because PIVCs are the most commonly inserted catheters, any barrier to penetration in that space is expected to limit growth of the overall catheter cap market.

Increased Usage of Antimicrobial PICCs and CVCs

The increasing use of antimicrobial PICCs and CVCs is another important limiter. Central lines are increasingly made with advanced materials designed to reduce bloodstream infections.

These antimicrobial catheters serve a similar purpose to catheter caps by reducing infection risk associated with catheter use. As these advanced devices continue to penetrate the market, some healthcare facilities may question whether additional products are necessary.

If hospitals believe antimicrobial catheters already provide sufficient infection protection, they may be less willing to purchase catheter caps for every access point. This may limit cap adoption, especially in facilities trying to control vascular access costs.

Cost Sensitivity in High-Volume Catheter Use

Catheter caps are used repeatedly because they are replaced each time the port is accessed. This creates strong recurring demand, but it also raises cost sensitivity.

In high-volume settings, multiple caps may be used per catheter each day. While this supports unit sales, it also increases the total cost of using caps as a standard protocol.

Facilities must weigh the cost of repeated cap use against the potential cost savings from preventing infections. Where infection risk is viewed as lower or budgets are constrained, adoption may be slower.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by competitive share analysis and forecast assumptions.
• Device scope: The report covers catheter caps used to disinfect needleless connectors and open catheter ports between accesses. These devices are used across vascular access settings as adjunct infection-prevention products.

Markets Covered and Segmentation

Catheter Cap Market

The report covers the global catheter cap market as a dedicated vascular access accessory segment.

Catheter caps are single-use disinfection devices designed to cover needleless connectors and open catheter ports between accesses. They typically contain an antiseptic agent that is released upon contact with residual fluid in the catheter hub.

These caps provide continuous passive disinfection and help reduce microbial colonization of the access point between line manipulations.

The market is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.

Demand is evaluated based on catheter utilization, central line adoption, infection-prevention protocols, PIVC penetration, long-term catheter use, demographic trends, and competitive positioning.

This structure helps manufacturers, investors, and strategy teams understand how catheter cap adoption is shaped by infection-prevention priorities, catheter placement volumes, product cost, and the expansion of advanced antimicrobial catheter technologies.

Competitive Analysis

In April 2024, 3M completed the planned spin-off of its health care business, formally launching Solventum Corp. as an independent company. In 2025, Solventum held the leading position in the catheter cap market with its Curos(TM) line of disinfection products.

Curos(TM) caps are designed to disinfect catheter ports and are suitable for needleless connectors and Luers. They contain an isopropyl alcohol solution that is proven to disinfect open catheter ports within a minute.

The products provide protection for up to 7 days and are replaced each time the port is accessed. Since catheter ports may be accessed multiple times per day, this results in repeated cap usage and supports recurring unit sales.

Solventum highlights the cost-saving potential of Curos(TM) caps compared with treating infections. While study results vary, many estimates suggest savings of more than $30,000 associated with Curos(TM) cap usage.

Solventum is also a leader in the catheter securement market, supported by products such as Tegaderm(TM) dressings and Curos(TM) caps. This broader vascular access infection-prevention portfolio strengthens the company's market position.

ICU Medical emerged as the second-leading player in the catheter cap market, particularly in dialysis caps, following its acquisition of Pursuit Vascular in 2019. Pursuit Vascular's ClearGuard(R) HD caps use chlorhexidine for disinfection and have been associated with around a 70% reduction in catheter-related bloodstream infections.

Technology and Practice Trends

Passive Disinfection

Passive disinfection is a key trend in the catheter cap market. Caps remain on the connector or catheter port between accesses, helping maintain disinfection without requiring repeated manual scrubbing alone.

This supports more consistent infection-prevention workflows.

Isopropyl Alcohol Caps

Isopropyl alcohol-based caps remain important in the market. Solventum's Curos(TM) line uses isopropyl alcohol solution to disinfect open catheter ports and needleless connectors.

These products are widely used as part of vascular access infection-prevention protocols.

Chlorhexidine-Based Dialysis Caps

Chlorhexidine-based caps are important in dialysis applications. ICU Medical's ClearGuard(R) HD caps use chlorhexidine for disinfection and target catheter-related bloodstream infection reduction in hemodialysis access.

This supports ICU Medical's position in dialysis-related catheter cap use.

Central Line Infection Prevention

Central lines such as PICCs and CVCs remain a major focus for catheter cap use because of their longer dwell times and higher infection risk.

This creates a major growth opportunity because only around 30% of central lines are estimated to use catheter caps.

PIVC Cost Challenge

PIVC adoption remains more difficult because the total cost of cap use can approach or exceed the cost of the catheter itself.

For broader PIVC adoption, companies may need stronger economic evidence or lower-cost cap options.

Competition from Antimicrobial Catheters

Antimicrobial PICCs and CVCs are increasingly used to reduce bloodstream infection risk. These products may reduce the perceived need for separate catheter caps.

This trend may limit cap adoption in some facilities.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global catheter cap market today, and how much is it expected to grow through 2032?
• How are unit sales, ASPs, and market values changing over time?
• How do catheter caps support passive disinfection of needleless connectors and open catheter ports?
• How does the rising use of long-term catheters affect cap demand?
• Why do PICCs and CVCs represent a major growth opportunity for catheter caps?
• How do catheter caps reduce catheter-related bloodstream infection risk?
• Why does repeated cap use create a cost barrier for PIVC adoption?
• How are antimicrobial PICCs and CVCs affecting catheter cap demand?
• Which companies lead the global catheter cap market?
• How are Solventum and ICU Medical positioned across standard catheter caps, dialysis caps, and vascular access infection-prevention workflows?

The Global Catheter Cap Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand passive disinfection adoption, and support commercial planning in the global catheter cap market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Catheter Cap Market

• 15.1 Executive Summary
  • 15.1.1 Global Catheter Cap Market Overview
  • 15.1.2 Competitive Analysis
  • 15.1.3 Regions Included
• 15.2 Introduction
• 15.3 Market Analysis And Forecast
• 15.4 Drivers And Limiters
  • 15.4.1 Market Drivers
  • 15.4.2 Market Limiters
• 15.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 15-1: Catheter Cap Market, Global, 2025 & 2032
• Chart 15-2: Catheter Cap Units Sold, Global, 2025
• Chart 15-3: Catheter Cap Market, Global, 2022 - 2032
• Chart 15-4: Leading Competitors, Catheter Cap Market, Global, 2025

LIST OF FIGURES

• Figure 15-1: Catheter Cap Regions Covered, Global (1 of 2)
• Figure 15-2: Catheter Cap Regions Covered, Global (2 of 2)
• Figure 15-3: Catheter Cap Market, Global, 2022 - 2032
• Figure 15-4: Units Sold by Region, Catheter Cap Market, Global, 2022 - 2032
• Figure 15-5: Average Selling Price by Region, Catheter Cap Market, Global, 2022 - 2032 (US$)
• Figure 15-6: Market Value by Region, Catheter Cap Market, Global, 2022 - 2032 (US$M)
• Figure 15-7: Leading Competitors, Catheter Cap Market, Global, 2025